Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Altmueller, Janine Dr.med. (16) Blankenstein, Thomas Prof. Dr. (32) Daniel, Peter Prof. Dr. (2) Di Virgilio, Michela Prof. Dr. (6) Graf, Robin Dr. (1) Henssen, Anton Prof. Dr. med. (1) Kammertöns, Thomas Dr. (9) Leisegang, Matthias Prof. Dr. rer. nat. (2) Pezzutto, Antonio Prof. Dr. (4) Rajewsky, Klaus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (1) Siffrin, Volker (1) Uckert, Wolfgang Prof. Dr. (4) (-) Bunse, Mario Dr. (1) (-) Chu, Van Trung Dr. (1) (-) Kopp, Joachim Dr. (2) (-) Semtner, Marcus Dr. (1) (-) Willimsky, Gerald Dr. (10) Entwicklungsbiologie / Signaltransduktion in Nerven und Muskelzellen (1) Experimentelle Ultrahochfeld-MR (4) Genetik metabolischer und reproduktiver Störungen (4) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genom-Editierung & Krankheitsmodelle (2) (-) Genomdiversifikation & Integrität (1) (-) Genomics (1) Immunregulation und Krebs (4) Kardiale MRT (2) Magnetic Resonance (4) Mathematische Modellierung zellulärer Prozesse (1) (-) Molekulare Immunologie und Gentherapie (12) Protein Production and Characterization (1) Proteom Dynamik (2) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) Proteomics and Metabolomics (1) RNA Biologie und Posttranscriptionale Regulation (3) Systembiologie von Gen-regulatorischen Elementen (1) Transgenics (2) 1997 (1) 1998 (1) (-) 2000 (3) (-) 2002 (1) 2005 (4) (-) 2007 (2) 2008 (2) 2010 (4) 2011 (1) (-) 2013 (5) (-) 2015 (3) 2016 (1) 2017 (1) 2018 (5) 2019 (3) 2020 (2) 2021 (1) 2022 (8) 2023 (8) 2024 (1) 14 Ergebnisse: Active Filter: Bunse, Mario Dr.Chu, Van Trung Dr.Kopp, Joachim Dr.Semtner, Marcus Dr.Willimsky, Gerald Dr.Genomdiversifikation & IntegritätGenomicsMolekulare Immunologie und Gentherapie 20002002200720132015 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein 01. August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder 01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein 01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel 01. Dezember 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein 01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel 01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein 01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Dezember 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein
01. August 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
01. Oktober 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
01. Mai 2000 / Bone Marrow Transplant Allogeneic vaccination for renal cell carcinoma: development and monitoring H. Pohla B. Frankenberger B. Stadlbauer R. Oberneder A. Hofstetter G. Willimsky A. Pezzutto B. Doerken T. Blankenstein D.J. Schendel
01. Dezember 2000 / Gene Ther Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse D.J. Schendel B. Frankenberger P. Jantzer S. Cayeux E. Noessner G. Willimsky B. Maget H. Pohla T. Blankenstein
01. November 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
01. Februar 2000 / Canc Res Interleukin-7/B7.1-encoding adenoviruses induce rejection of transplanted but not nontransplanted tumors G. Willimsky T. Blankenstein
01. März 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
08. Februar 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel